Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Am J Hypertens. 2011 Nov 24;25(3):354–358. doi: 10.1038/ajh.2011.224

Figure 1.

Figure 1

Systolic blood pressure (SBP) and urinary protein/creatinine ratio (UPCR). (a) Angiotensin II (AngII)-salt treatment elevated the blood pressure in mice. The hypertension was suppressed by olmesartan or hydralazine, but not by eplerenone. (b) Protein excretion in the urine was increased by AngII-salt. The increase in proteinuria was suppressed by olmesartan, but not by eplerenone or hydralazine. *P < 0.05 vs. vehicle, #P < 0.05 vs. AngII.